Generative AI for graph-based drug design: Recent advances and the way forward
Loading...
Access rights
openAccess
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A2 Katsausartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
Authors
Date
Department
Major/Subject
Mcode
Degree programme
Language
en
Pages
8
Series
Current Opinion in Structural Biology, Volume 84, pp. 1-8
Abstract
Discovering new promising molecule candidates that could translate into effective drugs is a key scientific pursuit. However, factors such as the vastness and discreteness of the molecular search space pose a formidable technical challenge in this quest. AI-driven generative models can effectively learn from data, and offer hope to streamline drug design. In this article, we review state of the art in generative models that operate on molecular graphs. We also shed light on some limitations of the existing methodology and sketch directions to harness the potential of AI for drug design tasks going forward.Description
Keywords
Other note
Citation
Garg, V 2024, 'Generative AI for graph-based drug design: Recent advances and the way forward', Current Opinion in Structural Biology, vol. 84, 102769, pp. 1-8. https://doi.org/10.1016/j.sbi.2023.102769